| Trial ID: | L1308 |
| Source ID: | NCT00319150
|
| Associated Drug: |
Erythropoietin
|
| Title: |
REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic|Drug Resistance
|
| Interventions: |
DRUG: erythropoietin
|
| Outcome Measures: |
Primary: Primary End-points:, December 31, 2009|Eprex® dose at the completion of the study period, December 31, 2009|Hemoglobin at completion of the study period (average of last 2 Hb measurements), December 31, 2009 | Secondary: Number of transfusions of packed red cells, December 31, 2009|# of active infections during the study period (active infection is defined in Appendix B), December 31, 2009|Hospitalization, December 31, 2009|Difference in HRQOL scores using Renal SF-36 scores taken at study start and completion study completion, December 31, 2009|Death, December 31, 2009
|
| Sponsor/Collaborators: |
Sponsor: Kingston Health Sciences Centre | Collaborators: Ortho Biotech, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
6
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-10
|
| Completion Date: |
2009-02
|
| Results First Posted: |
|
| Last Update Posted: |
2009-02-12
|
| Locations: |
Foothills Hospital, Calgary, Alberta, Canada|St. Paul's Hospital, Vancouver, British Columbia, Canada|Memorial University Medical Centre, St. John's, Newfoundland and Labrador, Canada|Kingston General Hospital, Kingston, Ontario, Canada|London Helath Sciences Centre, London, Ontario, Canada|Humber River Regional Hosptial, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00319150
|
